Before I really load the boat next week, I wanted some opinions on GIA execution...
anyone care to compare/contrast what makes Amarin fundamentally different from VVUS? Differences that pop into my mind are labeling restrictions and REMS, pharma mail order restriction; limited sales staff; side affects.
I guess what I'm wonder before I plunk some serious loot down is: are there any real comparisons? ty.
You are on the right track with VVUS. Many, many problems with their launch. I looked into this company and will take a pass for now. If AMRN launches alone, it will be much smoother, and successful faster, There will be hiccups, ( there always are ) , but results will show themselves rather quickly. Look to AFFY. Quality product, good launch, good results.